Pfizer PFE3.46%increase; green up pointing triangle said it is voluntarily withdrawing all lots of its sickle-cell drug Oxbryta in all markets where it is approved, two years after acquiring its ...

Sep. 12, 2024 — Researchers have found that being a carrier for sickle cell disease, known as having sickle cell trait, increases the risk of blood clots, a risk that is the same among diverse ...

Over 300 abnormal hemoglobins — such as sickle cell hemoglobin — have been discovered, most of which are either neutral or harmful to their carriers, and numerous thalassemias, which result ...

A VAMPIRE tomb has been unearthed with a sickle around its neck to prevent the "monster" from ever rising. The tomb was discovered by archaeologists deep beneath a church in northern Poland after ...

September Is Sickle Cell Awareness Month. While many people are familiar with sickle cell anemia, sickle cell traits have also plagued our community. Sickle cell trait (SCT) is an inherited blood ...

This article is part of “Innovations In: Sickle Cell Disease,” an editorially independent special report that was produced with financial support from Vertex Pharmaceuticals. Twenty-five years ...

This article is part of “Innovations In: Sickle Cell Disease,” an editorially independent special report that was produced with financial support from Vertex Pharmaceuticals. Kalpna Gupta was ...

Pfizer will voluntarily pull its sickle cell disease (SCD) drug Oxbryta from all markets worldwide, a major blow to a $5.4 billion acquisition the New York pharma made two years ago. Pfizer will ...

Sept 26 (Reuters) - U.S. drugmaker Pfizer (PFE.N), opens new tab said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where it is approved, citing risks ...

Conducted as part of the Sickle Cell Disease Implementation Consortium (SCDIC), the study included 2,282 individuals ages 15–45 years, with sickle cell disease. About 500 (22%) had HbSC.

Pfizer (NYSE:PFE) has voluntarily withdrawn all lots of its sickle cell disease drug Oxbryta, also known as voxelotor, over safety concerns. The pharmaceutical giant said Oxbryta will be withdrawn ...

Sickle cell disease (SCD) is an inherited health condition that slows the flow of red blood cells in your body. For people with SCD, hemoglobin S (a mutated protein that transports oxygen) causes ...